These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1008 related articles for article (PubMed ID: 33519919)
1. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma. Qi LW; Jia JH; Jiang CH; Hu JM Front Genet; 2020; 11():614566. PubMed ID: 33519919 [TBL] [Abstract][Full Text] [Related]
2. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets. Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805 [No Abstract] [Full Text] [Related]
3. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma. Bian S; Ni W; Zhu M; Song Q; Zhang J; Ni R; Zheng W Front Mol Biosci; 2020; 7():604766. PubMed ID: 33363211 [No Abstract] [Full Text] [Related]
5. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor. Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma. Wu X; Zhang X; Tao L; Dai X; Chen P Biomed Res Int; 2020; 2020():2053902. PubMed ID: 32733931 [TBL] [Abstract][Full Text] [Related]
7. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma. Fang Q; Chen H Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682 [TBL] [Abstract][Full Text] [Related]
8. The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma. Liu T; Sun L; Li ZZ; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P BMC Gastroenterol; 2023 May; 23(1):147. PubMed ID: 37170222 [TBL] [Abstract][Full Text] [Related]
9. Systematic Analyses of the Role of the Reader Protein of Shao XY; Dong J; Zhang H; Wu YS; Zheng L Front Mol Biosci; 2020; 7():577460. PubMed ID: 33344502 [TBL] [Abstract][Full Text] [Related]
10. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma. Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X Front Genet; 2022; 13():872186. PubMed ID: 35937991 [No Abstract] [Full Text] [Related]
11. N6-methyladenosine methylation-related genes Wang Y; Li T; Liu H; Liang Y; Wang G; Fu G; Takatsuki M; Qu H; Jing F; Li J; Jiang M Ann Transl Med; 2022 Dec; 10(24):1398. PubMed ID: 36660669 [TBL] [Abstract][Full Text] [Related]
12. The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma. Yu ZH; Feng ST; Zhang D; Cao XC; Yu Y; Wang X Cancer Cell Int; 2021 Jul; 21(1):385. PubMed ID: 34281544 [TBL] [Abstract][Full Text] [Related]
13. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma. Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760 [TBL] [Abstract][Full Text] [Related]
14. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis. Miao C; Fang X; Chen Y; Zhao Y; Guo Q Medicine (Baltimore); 2021 Dec; 100(49):e27689. PubMed ID: 34889221 [TBL] [Abstract][Full Text] [Related]
15. Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma. Pan J; Xu L; Pan H Front Oncol; 2020; 10():1444. PubMed ID: 32974164 [No Abstract] [Full Text] [Related]
16. A novel m6A-related prognostic signature for predicting the overall survival of hepatocellular carcinoma patients. Xie S; Wang Y; Huang J; Li G IET Syst Biol; 2022 Feb; 16(1):1-17. PubMed ID: 34647424 [TBL] [Abstract][Full Text] [Related]
17. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients. Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357 [TBL] [Abstract][Full Text] [Related]
18. The Effect of m6A Methylation Regulatory Factors on the Malignant Progression and Clinical Prognosis of Hepatocellular Carcinoma. Zhao Z; Yang L; Fang S; Zheng L; Wu F; Chen W; Song J; Chen M; Ji J Front Oncol; 2020; 10():1435. PubMed ID: 32974160 [TBL] [Abstract][Full Text] [Related]
19. The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma. Chen Y; Jiang X; Li X; Yan D; Liu J; Yang J; Yan S Ann Transl Med; 2021 Aug; 9(16):1346. PubMed ID: 34532483 [TBL] [Abstract][Full Text] [Related]
20. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer. Xu LC; Pan JX; Pan HD Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]